202 related articles for article (PubMed ID: 34250934)
1. Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System.
Jones E; Aigbogun MS; Pike J; Berry M; Houle CR; Husbands J
J Alzheimers Dis; 2021; 83(1):89-101. PubMed ID: 34250934
[TBL] [Abstract][Full Text] [Related]
2. Agitation-associated behavioral symptoms in mild cognitive impairment and Alzheimer's dementia.
Van der Mussele S; Le Bastard N; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
Aging Ment Health; 2015; 19(3):247-57. PubMed ID: 24962058
[TBL] [Abstract][Full Text] [Related]
3. Impact of Dementia-Related Behavioral Symptoms on Healthcare Resource Use and Caregiver Burden: Real-World Data from Europe and the United States.
Chekani F; Pike J; Jones E; Husbands J; Khandker RK
J Alzheimers Dis; 2021; 81(4):1567-1578. PubMed ID: 34057080
[TBL] [Abstract][Full Text] [Related]
4. A real-world assessment of healthcare costs associated with agitation in Alzheimer's dementia.
Grossberg G; Urganus A; Schein J; Bungay R; Cloutier M; Gauthier-Loiselle M; Chan D; Guerin A; Aggarwal J
J Med Econ; 2024; 27(1):99-108. PubMed ID: 38073468
[TBL] [Abstract][Full Text] [Related]
5. Multi-National, Cross-Sectional Survey of Healthcare Resource Utilization in Patients with All Stages of Cognitive Impairment, Analyzed by Disease Severity, Country, and Geographical Region.
Khandker RK; Ritchie CW; Black CM; Wood R; Jones E; Hu X; Ambegaonkar BM
J Alzheimers Dis; 2020; 75(4):1141-1152. PubMed ID: 32390613
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Agitation in Dementia on Caregivers: A Real-World Survey.
Schein J; Houle CR; Urganus AL; Jones E; Pike J; Husbands J; Willey CJ
J Alzheimers Dis; 2022; 88(2):663-677. PubMed ID: 35694920
[TBL] [Abstract][Full Text] [Related]
7. Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.
Ritchie CW; Khandker RK; Pike J; Black CM; Jones E; Ambegaonkar BM
J Alzheimers Dis; 2018; 64(3):899-910. PubMed ID: 29966202
[TBL] [Abstract][Full Text] [Related]
8. Distress Associated with Dementia-Related Psychosis and Agitation in Relation to Healthcare Utilization and Costs.
Maust DT; Kales HC; McCammon RJ; Blow FC; Leggett A; Langa KM
Am J Geriatr Psychiatry; 2017 Oct; 25(10):1074-1082. PubMed ID: 28754586
[TBL] [Abstract][Full Text] [Related]
9. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.
Lopez OL; Wisniewski SR; Becker JT; Boller F; DeKosky ST
Arch Neurol; 1999 Oct; 56(10):1266-72. PubMed ID: 10520944
[TBL] [Abstract][Full Text] [Related]
10. A retrospective chart review study to quantify the monthly medical resource use and costs of treating patients with treatment resistant depression in the United Kingdom.
Denee T; Ming T; Waller J; Bailey T; Rajkovic-Hooley O; Middleton-Dalby C; Le HH; Zhang Q; McCrone P; Taylor D
Curr Med Res Opin; 2021 Feb; 37(2):311-319. PubMed ID: 33253055
[TBL] [Abstract][Full Text] [Related]
11. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
12. Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer's disease.
Trzepacz PT; Yu P; Bhamidipati PK; Willis B; Forrester T; Tabas L; Schwarz AJ; Saykin AJ;
Alzheimers Dement; 2013 Oct; 9(5 Suppl):S95-S104.e1. PubMed ID: 23253778
[TBL] [Abstract][Full Text] [Related]
13. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol for agitation in dementia.
Lonergan E; Luxenberg J; Colford J
Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis.
Aigbogun MS; Stellhorn R; Hartry A; Baker RA; Fillit H
BMC Neurol; 2019 Feb; 19(1):33. PubMed ID: 30819136
[TBL] [Abstract][Full Text] [Related]
16. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
[TBL] [Abstract][Full Text] [Related]
17. The Minimum Data Set Agitated and Reactive Behavior Scale: Measuring Behaviors in Nursing Home Residents With Dementia.
McCreedy E; Ogarek JA; Thomas KS; Mor V
J Am Med Dir Assoc; 2019 Dec; 20(12):1548-1552. PubMed ID: 31678075
[TBL] [Abstract][Full Text] [Related]
18. Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study.
Herrmann N; Cappell J; Eryavec GM; Lanctôt KL
CNS Drugs; 2011 May; 25(5):425-33. PubMed ID: 21476613
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and monetary costs associated with agitation in UK care home residents with advanced dementia: a prospective cohort study.
Buylova Gola A; Morris S; Candy B; Davis S; King M; Kupeli N; Leavey G; Moore K; Nazareth I; Omar R; Vickerstaff V; Jones L; Sampson EL
Int Psychogeriatr; 2020 Mar; 32(3):359-370. PubMed ID: 31948510
[TBL] [Abstract][Full Text] [Related]
20. Potentially modifiable factors associated with agitation and aggression in Alzheimer's disease: results of the ICTUS study.
de Mauleon A; Soto M; Ousset PJ; Nourhashemi F; Lepage B; Vellas B
Int Psychogeriatr; 2019 Oct; 31(10):1509-1516. PubMed ID: 30714541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
